Affordable Access

Publisher Website

Effect of high dose diethylstilbestrol and ICRF-159 on the growth and metastases of the R3327 MAT-LyLu prostate-derived tumor

Authors
Journal
Cancer Letters
0304-3835
Publisher
Elsevier
Publication Date
Volume
13
Issue
2
Identifiers
DOI: 10.1016/0304-3835(81)90140-3
Disciplines
  • Medicine

Abstract

Abstract The R3327 MAT-LyLu, a lymphotrophic, metastatic prostate-derived rat tumor was treated with high dose diethylstilbestrol or the chemotherapeutic agent ICRF-159. Both drugs inhibited the growth of the primary tumor and the development of metastases.

There are no comments yet on this publication. Be the first to share your thoughts.